Arito Mitsumi, Horiba Taro, Hachimura Satoshi, Inoue Jun, Sato Ryuichiro
Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
J Biol Chem. 2008 May 30;283(22):15224-31. doi: 10.1074/jbc.M800910200. Epub 2008 Apr 9.
The destiny and activity of sterol regulatory element-binding proteins (SREBPs) in the nucleus are regulated by modification with ubiquitin, small ubiquitin-like modifier (SUMO), or phosphorus. ERK-dependent phosphorylation causes an increase in their transcriptional activity, whereas SUMO modification halts it. We hypothesized a causal linkage between phosphorylation and sumoylation because their sites are very closely located in SREBP-1 and -2 molecules. When Ser(455), a phosphorylation site in SREBP-2, was substituted with Ala, this SREBP-2 mutant was more efficiently modified by SUMO-1. On the other hand, substitution of Asp inhibited SUMO conjugation, mimicking phosphoserine. When cells were cultured with insulin-like growth factor-1, sumoylation of SREBP-2 was decreased with an increase in its phosphorylation, but SREBP-2(S455A) was continuously sumoylated. An ERK cascade inhibitor, U0126, inversely augmented SUMO modification of SREBP-2. Insulin-like growth factor-1 treatment stimulated the expression of SREBP target genes such as the low density lipoprotein (LDL) receptor, squalene synthase, and hydroxymethylglutaryl-CoA synthase genes. These results indicate that growth factor-induced phosphorylation of SREBP-2 inhibits sumoylation, thereby facilitating SREBP transcriptional activity. Glutathione S-transferase pulldown assays revealed that wild-type SREBP-2, but not a mutant lacking Lys(464), interacts with HDAC3 preferentially among the histone deacetylase family members. HDAC3 small interfering RNA induced gene expression of the LDL receptor and thereby augmented fluorescently labeled LDL uptake in HepG2 cells. In summary, growth factors inhibit sumoylation of SREBPs through their phosphorylation, thus avoiding the recruitment of an HDAC3 corepressor complex and stimulating the lipid uptake and synthesis required for cell growth.
固醇调节元件结合蛋白(SREBPs)在细胞核中的命运和活性受泛素、小泛素样修饰物(SUMO)或磷酸化修饰的调控。细胞外调节蛋白激酶(ERK)依赖性磷酸化导致其转录活性增加,而SUMO修饰则使其转录活性停止。我们推测磷酸化和SUMO化之间存在因果联系,因为它们的位点在SREBP-1和-2分子中位置非常接近。当SREBP-2中的磷酸化位点Ser(455)被丙氨酸替代时,这种SREBP-2突变体被SUMO-1更有效地修饰。另一方面,天冬氨酸替代抑制了SUMO缀合,模拟了磷酸丝氨酸。当细胞用胰岛素样生长因子-1培养时,SREBP-2的SUMO化随着其磷酸化增加而减少,但SREBP-2(S455A)持续被SUMO化。ERK级联抑制剂U0126反向增强了SREBP-2的SUMO修饰。胰岛素样生长因子-1处理刺激了SREBP靶基因如低密度脂蛋白(LDL)受体、角鲨烯合酶和羟甲基戊二酰辅酶A合酶基因的表达。这些结果表明,生长因子诱导的SREBP-2磷酸化抑制了SUMO化,从而促进了SREBP转录活性。谷胱甘肽S-转移酶下拉试验表明,野生型SREBP-2而非缺乏Lys(464)的突变体在组蛋白去乙酰化酶家族成员中优先与HDAC3相互作用。HDAC3小干扰RNA诱导LDL受体的基因表达,从而增强了HepG2细胞中荧光标记的LDL摄取。总之,生长因子通过磷酸化抑制SREBPs的SUMO化,从而避免募集HDAC3共抑制复合物并刺激细胞生长所需的脂质摄取和合成。